RESONANCE HEALTH LIMITED - Announcements

2.63%

3.9¢

Market Cap $17.88M

Technology Scientific & Technical Instruments

Resonance Health Limited is an Australia-based healthcare technology and services company... Resonance Health Limited is an Australia-based healthcare technology and services company engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its portfolio includes Core Lab and artificial intelligence (AI)-powered products to partner with clinicians and radiologists for diagnosis, and management of patients. Its core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. Its other SaMDs include Cardiac T2, for the assessment of iron in the heart, and HepaFat-Scan for the assessment of fat in and around the liver. It also has several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart. It operates as the Clinical Trial Research Organisation (CRO) and local sponsor for a major global pharma company's clinical trial in Australia of a new drug compound.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/25	749.06KB	Share
RHT	TrialsWest Expands with New Clinical Trial Site	PRICE SENSITIVE	08/07/25	1001.71KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/25	1.39MB	Share
RHT	Half Year Results Presentation	PRICE SENSITIVE	28/02/25	2.32MB	Share
RHT	Half Year Results	PRICE SENSITIVE	28/02/25	505.37KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/25	833.11KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/01/25	1.37MB	Share
RHT	Non-deal Investor Roadshow Presentation	PRICE SENSITIVE	02/12/24	2.29MB	Share
RHT	AGM Presentation	PRICE SENSITIVE	28/11/24	2.13MB	Share
RHT	Resonance Contracted by Major Global Pharma	PRICE SENSITIVE	19/11/24	290.18KB	Share
RHT	Trading Halt	PRICE SENSITIVE	18/11/24	293.07KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/24	1.36MB	Share
RHT	Full Year Results Presentation	PRICE SENSITIVE	30/08/24	1.84MB	Share
RHT	Full Year Results	PRICE SENSITIVE	30/08/24	398.34KB	Share
RHT	Appendix 4E & Annual Report to Shareholders	PRICE SENSITIVE	30/08/24	3.7MB	Share
RHT	TrialsWest Expansion - New Trial Site	PRICE SENSITIVE	08/08/24	312.34KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	689.79KB	Share
RHT	Completion of TrialsWest Acquisition	PRICE SENSITIVE	31/05/24	296.26KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/24	1.37MB	Share
RHT	Investor Presentation - TrialsWest Acquisition	PRICE SENSITIVE	02/04/24	1.52MB	Share
RHT	Acquisition of TrialsWest Group	PRICE SENSITIVE	02/04/24	280.05KB	Share
RHT	Trading Halt	PRICE SENSITIVE	28/03/24	620.46KB	Share
RHT	Pause in Trading	PRICE SENSITIVE	28/03/24	117.89KB	Share
RHT	Collaboration with Micron, Inc.	PRICE SENSITIVE	27/03/24	315.39KB	Share
RHT	Half Yearly Report Results Announcement	PRICE SENSITIVE	28/02/24	391.82KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/24	732.25KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/24	770.62KB	Share
RHT	Notification of buy-back - RHT	PRICE SENSITIVE	24/11/23	22.71KB	Share
RHT	AGM Presentation	PRICE SENSITIVE	16/11/23	1.46MB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/23	1.63MB	Share
RHT	Annual Report & Appendix 4E	PRICE SENSITIVE	30/08/23	1.71MB	Share
RHT	Resonance Contracted by Major Global Pharma	PRICE SENSITIVE	18/08/23	309.22KB	Share
RHT	Trading Halt	PRICE SENSITIVE	17/08/23	216.51KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	25/07/23	1.48MB	Share
RHT	Management Transition	PRICE SENSITIVE	23/06/23	285.16KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	1.37MB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	559.79KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	2.34MB	Share
RHT	MRI Fibrosis Provisional Patent Application Lodged	PRICE SENSITIVE	21/12/22	332.5KB	Share
RHT	Investor Presentation	PRICE SENSITIVE	24/11/22	6.6MB	Share
RHT	Resonance Health Contracted for Two New Clinical Trials	PRICE SENSITIVE	11/11/22	420.39KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	1.55MB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	30/08/22	1.68MB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	914.14KB	Share
RHT	FerriScan Now Available on 3 Tesla (3T) MRI Machines	PRICE SENSITIVE	25/07/22	323.74KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	02/05/22	1.51MB	Share
RHT	Platform Integration & Partnership Agreement with CARPL.ai	PRICE SENSITIVE	05/04/22	305.55KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/22	612.83KB	Share
RHT	US CPT Code Confirmation for LiverSmart	PRICE SENSITIVE	07/02/22	374.17KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	376.59KB	Share
RHT	Resonance Health Enters China - Pharma Contract Signed	PRICE SENSITIVE	27/01/22	2.25MB	Share
RHT	Resonance Health Contracted for Third Party Clinical Trial	PRICE SENSITIVE	25/01/22	655.94KB	Share
RHT	US FDA Clearance for LiverSmart	PRICE SENSITIVE	30/12/21	1.44MB	Share
RHT	ASO Project New Data	PRICE SENSITIVE	20/12/21	571.67KB	Share
RHT	LiverSmart Submitted to FDA for US Regulatory Clearance	PRICE SENSITIVE	03/12/21	246.91KB	Share
RHT	Investor Presentation - Positioning for Growth	PRICE SENSITIVE	25/11/21	2.61MB	Share
RHT	ASO R&D Project - Filing of Two Patent Applications	PRICE SENSITIVE	23/11/21	251.95KB	Share
RHT	Thalassaemia International Federation to Deploy FerriSmart	PRICE SENSITIVE	12/11/21	274.17KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/21	479.75KB	Share
RHT	Sales & Marketing Update	PRICE SENSITIVE	14/10/21	284.71KB	Share
RHT	New AI Medical Device	PRICE SENSITIVE	13/10/21	260.2KB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	30/08/21	992.56KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	02/08/21	1.41MB	Share
RHT	Appointment of Managing Director	PRICE SENSITIVE	28/06/21	263.78KB	Share
RHT	Resignation of CEO & Management Changes	PRICE SENSITIVE	04/06/21	252.47KB	Share
RHT	Filing of Patent Application	PRICE SENSITIVE	24/05/21	550.02KB	Share
RHT	R&D Update - Molecular Medicine ASO Project	PRICE SENSITIVE	17/05/21	253.5KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/21	369.25KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	1.04MB	Share
RHT	HepaFat-AI receives CE Marking	PRICE SENSITIVE	24/02/21	252.4KB	Share
RHT	HepaFat-AI Receives TGA Approval	PRICE SENSITIVE	18/02/21	280.7KB	Share
RHT	Trading Halt	PRICE SENSITIVE	17/02/21	570.06KB	Share
RHT	Pause in Trading	PRICE SENSITIVE	17/02/21	116.7KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/21	397.37KB	Share
RHT	HepaFat-AI Incorporated into Blackford Analysis	PRICE SENSITIVE	24/12/20	153.07KB	Share
RHT	HepaFat-AI gains US FDA clearance	PRICE SENSITIVE	09/12/20	553.37KB	Share
RHT	Trading Halt	PRICE SENSITIVE	08/12/20	198.54KB	Share
RHT	Pause in Trading	PRICE SENSITIVE	08/12/20	116.61KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	26/10/20	375.72KB	Share
RHT	New Pulmonary Embolism AI Solution Developed	PRICE SENSITIVE	06/10/20	151.84KB	Share
RHT	Execution of Licence Agreement	PRICE SENSITIVE	10/09/20	441.01KB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	20/08/20	420.51KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/20	397.3KB	Share
RHT	Resonance Health Files New Provisional Patent	PRICE SENSITIVE	25/05/20	142.25KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/20	709.11KB	Share
RHT	Market Update	PRICE SENSITIVE	31/03/20	132.87KB	Share
RHT	Controlled Placement Facility	PRICE SENSITIVE	19/03/20	71.97KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/20	1.15MB	Share
RHT	Licencee & Royalty Agreement with 3DR Laboratories	PRICE SENSITIVE	04/02/20	342.92KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/20	615.03KB	Share
RHT	Resonance Health Partners with Siemens healthineers	PRICE SENSITIVE	28/11/19	107.3KB	Share
RHT	New AI Tool for Automated Assessment of Liver Fat	PRICE SENSITIVE	21/11/19	238.73KB	Share
RHT	Resonance Health Files Provisional Patent	PRICE SENSITIVE	20/11/19	238.71KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/19	613.15KB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	27/08/19	562.49KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/19	633.31KB	Share
RHT	Resonance Health contracted new clinical trials	PRICE SENSITIVE	19/07/19	256.83KB	Share
RHT	R&D Activities Update and Appendix 3B	PRICE SENSITIVE	30/04/19	974.05KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	16/04/19	385.85KB	Share
RHT	Response to ASX Price and Volume Query	PRICE SENSITIVE	15/04/19	220.51KB	Share

RHT Quarterly Activities/Appendix 4C Cash Flow Report
31/07/25	PRICE SENSITIVE	749.06KB	Share
RHT TrialsWest Expands with New Clinical Trial Site
08/07/25	PRICE SENSITIVE	1001.71KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
29/04/25	PRICE SENSITIVE	1.39MB	Share
RHT Half Year Results Presentation
28/02/25	PRICE SENSITIVE	2.32MB	Share
RHT Half Year Results
28/02/25	PRICE SENSITIVE	505.37KB	Share
RHT Half Yearly Report and Accounts
28/02/25	PRICE SENSITIVE	833.11KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
28/01/25	PRICE SENSITIVE	1.37MB	Share
RHT Non-deal Investor Roadshow Presentation
02/12/24	PRICE SENSITIVE	2.29MB	Share
RHT AGM Presentation
28/11/24	PRICE SENSITIVE	2.13MB	Share
RHT Resonance Contracted by Major Global Pharma
19/11/24	PRICE SENSITIVE	290.18KB	Share
RHT Trading Halt
18/11/24	PRICE SENSITIVE	293.07KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
28/10/24	PRICE SENSITIVE	1.36MB	Share
RHT Full Year Results Presentation
30/08/24	PRICE SENSITIVE	1.84MB	Share
RHT Full Year Results
30/08/24	PRICE SENSITIVE	398.34KB	Share
RHT Appendix 4E & Annual Report to Shareholders
30/08/24	PRICE SENSITIVE	3.7MB	Share
RHT TrialsWest Expansion - New Trial Site
08/08/24	PRICE SENSITIVE	312.34KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	689.79KB	Share
RHT Completion of TrialsWest Acquisition
31/05/24	PRICE SENSITIVE	296.26KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
29/04/24	PRICE SENSITIVE	1.37MB	Share
RHT Investor Presentation - TrialsWest Acquisition
02/04/24	PRICE SENSITIVE	1.52MB	Share
RHT Acquisition of TrialsWest Group
02/04/24	PRICE SENSITIVE	280.05KB	Share
RHT Trading Halt
28/03/24	PRICE SENSITIVE	620.46KB	Share
RHT Pause in Trading
28/03/24	PRICE SENSITIVE	117.89KB	Share
RHT Collaboration with Micron, Inc.
27/03/24	PRICE SENSITIVE	315.39KB	Share
RHT Half Yearly Report Results Announcement
28/02/24	PRICE SENSITIVE	391.82KB	Share
RHT Half Yearly Report and Accounts
28/02/24	PRICE SENSITIVE	732.25KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
30/01/24	PRICE SENSITIVE	770.62KB	Share
RHT Notification of buy-back - RHT
24/11/23	PRICE SENSITIVE	22.71KB	Share
RHT AGM Presentation
16/11/23	PRICE SENSITIVE	1.46MB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
30/10/23	PRICE SENSITIVE	1.63MB	Share
RHT Annual Report & Appendix 4E
30/08/23	PRICE SENSITIVE	1.71MB	Share
RHT Resonance Contracted by Major Global Pharma
18/08/23	PRICE SENSITIVE	309.22KB	Share
RHT Trading Halt
17/08/23	PRICE SENSITIVE	216.51KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
25/07/23	PRICE SENSITIVE	1.48MB	Share
RHT Management Transition
23/06/23	PRICE SENSITIVE	285.16KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	1.37MB	Share
RHT Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	559.79KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	2.34MB	Share
RHT MRI Fibrosis Provisional Patent Application Lodged
21/12/22	PRICE SENSITIVE	332.5KB	Share
RHT Investor Presentation
24/11/22	PRICE SENSITIVE	6.6MB	Share
RHT Resonance Health Contracted for Two New Clinical Trials
11/11/22	PRICE SENSITIVE	420.39KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	1.55MB	Share
RHT Preliminary Final Report
30/08/22	PRICE SENSITIVE	1.68MB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	914.14KB	Share
RHT FerriScan Now Available on 3 Tesla (3T) MRI Machines
25/07/22	PRICE SENSITIVE	323.74KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
02/05/22	PRICE SENSITIVE	1.51MB	Share
RHT Platform Integration & Partnership Agreement with CARPL.ai
05/04/22	PRICE SENSITIVE	305.55KB	Share
RHT Half Yearly Report and Accounts
28/02/22	PRICE SENSITIVE	612.83KB	Share
RHT US CPT Code Confirmation for LiverSmart
07/02/22	PRICE SENSITIVE	374.17KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	376.59KB	Share
RHT Resonance Health Enters China - Pharma Contract Signed
27/01/22	PRICE SENSITIVE	2.25MB	Share
RHT Resonance Health Contracted for Third Party Clinical Trial
25/01/22	PRICE SENSITIVE	655.94KB	Share
RHT US FDA Clearance for LiverSmart
30/12/21	PRICE SENSITIVE	1.44MB	Share
RHT ASO Project New Data
20/12/21	PRICE SENSITIVE	571.67KB	Share
RHT LiverSmart Submitted to FDA for US Regulatory Clearance
03/12/21	PRICE SENSITIVE	246.91KB	Share
RHT Investor Presentation - Positioning for Growth
25/11/21	PRICE SENSITIVE	2.61MB	Share
RHT ASO R&D Project - Filing of Two Patent Applications
23/11/21	PRICE SENSITIVE	251.95KB	Share
RHT Thalassaemia International Federation to Deploy FerriSmart
12/11/21	PRICE SENSITIVE	274.17KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
29/10/21	PRICE SENSITIVE	479.75KB	Share
RHT Sales & Marketing Update
14/10/21	PRICE SENSITIVE	284.71KB	Share
RHT New AI Medical Device
13/10/21	PRICE SENSITIVE	260.2KB	Share
RHT Preliminary Final Report
30/08/21	PRICE SENSITIVE	992.56KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
02/08/21	PRICE SENSITIVE	1.41MB	Share
RHT Appointment of Managing Director
28/06/21	PRICE SENSITIVE	263.78KB	Share
RHT Resignation of CEO & Management Changes
04/06/21	PRICE SENSITIVE	252.47KB	Share
RHT Filing of Patent Application
24/05/21	PRICE SENSITIVE	550.02KB	Share
RHT R&D Update - Molecular Medicine ASO Project
17/05/21	PRICE SENSITIVE	253.5KB	Share
RHT Appendix 4C - quarterly
29/04/21	PRICE SENSITIVE	369.25KB	Share
RHT Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	1.04MB	Share
RHT HepaFat-AI receives CE Marking
24/02/21	PRICE SENSITIVE	252.4KB	Share
RHT HepaFat-AI Receives TGA Approval
18/02/21	PRICE SENSITIVE	280.7KB	Share
RHT Trading Halt
17/02/21	PRICE SENSITIVE	570.06KB	Share
RHT Pause in Trading
17/02/21	PRICE SENSITIVE	116.7KB	Share
RHT Appendix 4C - quarterly
28/01/21	PRICE SENSITIVE	397.37KB	Share
RHT HepaFat-AI Incorporated into Blackford Analysis
24/12/20	PRICE SENSITIVE	153.07KB	Share
RHT HepaFat-AI gains US FDA clearance
09/12/20	PRICE SENSITIVE	553.37KB	Share
RHT Trading Halt
08/12/20	PRICE SENSITIVE	198.54KB	Share
RHT Pause in Trading
08/12/20	PRICE SENSITIVE	116.61KB	Share
RHT Appendix 4C - quarterly
26/10/20	PRICE SENSITIVE	375.72KB	Share
RHT New Pulmonary Embolism AI Solution Developed
06/10/20	PRICE SENSITIVE	151.84KB	Share
RHT Execution of Licence Agreement
10/09/20	PRICE SENSITIVE	441.01KB	Share
RHT Preliminary Final Report
20/08/20	PRICE SENSITIVE	420.51KB	Share
RHT Appendix 4C - quarterly
28/07/20	PRICE SENSITIVE	397.3KB	Share
RHT Resonance Health Files New Provisional Patent
25/05/20	PRICE SENSITIVE	142.25KB	Share
RHT Appendix 4C - quarterly
28/04/20	PRICE SENSITIVE	709.11KB	Share
RHT Market Update
31/03/20	PRICE SENSITIVE	132.87KB	Share
RHT Controlled Placement Facility
19/03/20	PRICE SENSITIVE	71.97KB	Share
RHT Half Yearly Report and Accounts
21/02/20	PRICE SENSITIVE	1.15MB	Share
RHT Licencee & Royalty Agreement with 3DR Laboratories
04/02/20	PRICE SENSITIVE	342.92KB	Share
RHT Appendix 4C - quarterly
29/01/20	PRICE SENSITIVE	615.03KB	Share
RHT Resonance Health Partners with Siemens healthineers
28/11/19	PRICE SENSITIVE	107.3KB	Share
RHT New AI Tool for Automated Assessment of Liver Fat
21/11/19	PRICE SENSITIVE	238.73KB	Share
RHT Resonance Health Files Provisional Patent
20/11/19	PRICE SENSITIVE	238.71KB	Share
RHT Appendix 4C - quarterly
28/10/19	PRICE SENSITIVE	613.15KB	Share
RHT Preliminary Final Report
27/08/19	PRICE SENSITIVE	562.49KB	Share
RHT Appendix 4C - quarterly
29/07/19	PRICE SENSITIVE	633.31KB	Share
RHT Resonance Health contracted new clinical trials
19/07/19	PRICE SENSITIVE	256.83KB	Share
RHT R&D Activities Update and Appendix 3B
30/04/19	PRICE SENSITIVE	974.05KB	Share
RHT Appendix 4C - quarterly
16/04/19	PRICE SENSITIVE	385.85KB	Share
RHT Response to ASX Price and Volume Query
15/04/19	PRICE SENSITIVE	220.51KB	Share

REFRESH

1 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change 0.001(2.63%)		Mkt cap ! $17.88M

Open	High	Low	Value	Volume
3.8¢	3.9¢	3.8¢	$7.048K	181.6K

Buyers (Bids)

No.	Vol.	Price($)
1	333363	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.1¢	186666	1

View Market Depth

No.	Vol.	Price($)
2	399381	0.036
1	160000	0.035
3	291719	0.034
1	99998	0.030
1	100000	0.028

Price($)	Vol.	No.
0.038	20542	1
0.039	146095	2
0.041	186666	1
0.042	68181	1
0.043	1148401	1

Last trade - 11.47am 11/08/2025 (20 minute delay)


Last 3.8¢		Change 0.001 ( 0.00 %)
Open	High	Low	Volume
3.8¢	3.8¢	3.8¢	37027
Last updated 11.37am 11/08/2025 ?

RHT (ASX) Chart

RESONANCE HEALTH LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available